© 2023 MJH Life Sciences™ and Nutritional Outlook. All rights reserved.
According to the companies, the product is supported by a double-blind, placebo-controlled human study, pending publication, to support digestive health and enhance mood.
NXT USA and Shanghai Freemen are collaborating to launch Digexin at SupplySide West, taking place on November 2 and 3, 2022 in Las Vegas, NV. According to the companies, the product is supported by a double-blind, placebo-controlled human study, pending publication, to support digestive health and enhance mood, as well as other life measures. A second, larger clinical trial is underway to further validate the ingredient’s benefits.
“Digexin is a new approach in the in the digestive category, promoting regularity while also promoting mood, sleep and stress support,” says Eric Anderson, managing director, NXT USA, in a press release. “We are excited to partner with Shanghai Freemen to expand the market for consumers that desire both benefits.For many people, this can be the difference between a good day, and a not-so-good day!”
“We are excited to be bringing Digexin to market with an accomplished partner like NXT USA,” said Hank Li, president of Shanghai Freemen Americas. “As our first proprietary ingredient, we see substantial potential in Digexin and its clinically validated benefits. This is an important step as we expand our capabilities to meet evolving customer needs. We will initially offer Digexin in the US where consumers understand the significant health and wellness role of the gut-brain axis. But with 25 years’ experience and offices in the US, EU, China, Australia, and Japan, we are optimistic for broader success.”
The benefits demonstrated in the Digexin’s first clinical study included:
Digexin will be showcased at SupplySide West at the the Shanghai Freemen Booth, #7111.